Total Payments
$263,805
2024 Payments
$25,238
Companies
73
Transactions
1,982
Medicare Patients
6,351
Medicare Billing
$711,176
Payment Breakdown by Category
Other$150,495 (57.0%)
Consulting$62,410 (23.7%)
Food & Beverage$34,351 (13.0%)
Travel$16,257 (6.2%)
Education$292.56 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $150,495 | 100 | 57.0% |
| Consulting Fee | $62,410 | 30 | 23.7% |
| Food and Beverage | $34,351 | 1,779 | 13.0% |
| Travel and Lodging | $16,257 | 60 | 6.2% |
| Education | $292.56 | 13 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $145,440 | 277 | $0 (2024) |
| Amgen Inc. | $59,184 | 145 | $0 (2024) |
| ABBVIE INC. | $18,449 | 202 | $0 (2024) |
| Allergan, Inc. | $12,738 | 66 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $3,715 | 129 | $0 (2024) |
| Novo Nordisk Inc | $3,171 | 185 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $3,066 | 7 | $0 (2017) |
| Eli Lilly and Company | $2,250 | 1 | $0 (2020) |
| GlaxoSmithKline, LLC. | $1,940 | 111 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,750 | 98 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,238 | 258 | Amgen Inc. ($12,316) |
| 2023 | $62,236 | 348 | Amgen Inc. ($30,898) |
| 2022 | $42,402 | 303 | Janssen Pharmaceuticals, Inc ($21,318) |
| 2021 | $29,384 | 216 | Janssen Pharmaceuticals, Inc ($19,617) |
| 2020 | $22,474 | 206 | Janssen Pharmaceuticals, Inc ($11,687) |
| 2019 | $14,101 | 188 | Janssen Pharmaceuticals, Inc ($11,027) |
| 2018 | $32,535 | 237 | Janssen Pharmaceuticals, Inc ($24,097) |
| 2017 | $35,435 | 226 | Janssen Pharmaceuticals, Inc ($29,830) |
All Payment Transactions
1,982 individual payment records from CMS Open Payments — Page 1 of 80
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Cardio-renal | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: DIABETES | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.92 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Cardio-renal | ||||||
| 12/09/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.96 | General |
| 12/06/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $5.19 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.95 | General |
| Category: Cardiovascular | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Inflammation | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: DIABETES | ||||||
| 11/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.77 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,238 | 2,124 | $281,405 | $103,488 |
| 2022 | 12 | 1,568 | 2,729 | $385,415 | $128,719 |
| 2021 | 13 | 1,832 | 3,628 | $461,360 | $277,409 |
| 2020 | 21 | 1,713 | 3,094 | $384,335 | $201,560 |
Total Patients
6,351
Total Services
11,575
Medicare Billing
$711,176
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 16 | 17 | $1,870 | $1,057 | 56.5% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 21 | 21 | $2,100 | $980.70 | 46.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 17 | 50 | $1,750 | $576.28 | 32.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 20 | 20 | $700.00 | $356.72 | 51.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 22 | 22 | $1,650 | $314.64 | 19.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 11 | 11 | $385.00 | $178.00 | 46.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 12 | 44 | $440.00 | $66.59 | 15.1% |
About Dr. Michael Attanasio, D.O
Dr. Michael Attanasio, D.O is a Family Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174593958.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Attanasio, D.O has received a total of $263,805 in payments from pharmaceutical and medical device companies, with $25,238 received in 2024. These payments were reported across 1,982 transactions from 73 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($150,495).
As a Medicare-enrolled provider, Attanasio has provided services to 6,351 Medicare beneficiaries, totaling 11,575 services with total Medicare billing of $711,176. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Philadelphia, PA
- Active Since 01/25/2006
- Last Updated 12/27/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1174593958
Products in Payments
- XARELTO (Drug) $88,517
- Repatha (Biological) $58,259
- INVOKANA (Drug) $56,923
- UBRELVY (Drug) $18,645
- VRAYLAR (Drug) $6,981
- QULIPTA (Drug) $4,968
- JARDIANCE (Drug) $3,377
- Trintellix (Drug) $3,177
- Ozempic (Drug) $1,610
- TRELEGY ELLIPTA (Drug) $1,426
- FARXIGA (Drug) $1,390
- TRULICITY (Drug) $915.48
- Kerendia (Drug) $860.21
- BREZTRI (Drug) $851.93
- ENTRESTO (Drug) $760.82
- Vascepa (Drug) $712.58
- XIFAXAN (Drug) $637.74
- Otezla (Drug) $530.23
- JANUVIA (Drug) $454.48
- SYMBICORT (Drug) $430.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Philadelphia
Dr. Deborah Witt, M.d, M.D
Family Medicine — Payments: $226,164
Family Medicine $226,164
Jonah Mink, Md, MD
Family Medicine — Payments: $146,427
Family Medicine $146,427
Celia Ezidiegwu, Md, MD
Family Medicine — Payments: $117,796
Family Medicine $117,796
Dr. Glenn Rosen, Md, MD
Family Medicine — Payments: $77,390
Family Medicine $77,390
Dr. Casey Lafferty, D.o, D.O
Family Medicine — Payments: $54,627
Family Medicine $54,627
Dr. Daniel Schwartz, Do, DO
Family Medicine — Payments: $33,185
Family Medicine $33,185